Literature DB >> 9238113

The adaptive immune response to major surgery in the neonate.

H W Grant1, A A Chuturgoon, D G Kenoyer, T Doorasamy.   

Abstract

The effect of major surgery on components of the adaptive immune response in babies has not previously been reported. In a prospective study, eight neonates undergoing uncomplicated surgery for repair of esophageal atresia were investigated. They were compared with ten age-matched normal babies not undergoing surgery. The parameters of the immune response investigated were: total leukocytes (WBC), lymphocytes and their subsets (T-helper, T-suppressor, natural killer [NK], B-lymphocytes), monocytes, immunoglobulins (Ig) G and M, the cytokines tumor necrosis factor-alpha (TNF-alpha) and interleukin 1-beta (Il-1beta), and C-reactive protein (CRP), an acute-phase protein. When compared to the normal controls, the operated group showed a fall in all types of WBC following surgery, but only the falls in B-lymphocytes and NK cells were significant on postoperative day 3 (P < 0.05). The suppression in WBC was temporary, and by day 7 the operated group had significantly higher numbers of total WBC and T-helper cells than the controls (P < 0.05), who were undergoing their physiological postpartum fall in WBC. Within the operated group, there was a significant fall in the numbers of total lymphocytes, T-suppressors, and B-lymphocytes compared to preoperative levels (P < 0.01). The ratio of T-helper/T-suppressor cells increased significantly following surgery. There was a vigorous immune response in terms of the humoral factors: CRP, TNF-alpha, and Il-1beta all rose significantly postoperatively (P < 0.02).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9238113     DOI: 10.1007/BF01258708

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  24 in total

1.  Cellular (T cell) immunity in the human newborn.

Authors:  E R Stiehm; H S Winter; Y J Bryson
Journal:  Pediatrics       Date:  1979-11       Impact factor: 7.124

2.  Cell-mediated immunity and immunoglobulin levels in light-for-date infants.

Authors:  C Bhaskaram; N Raghuramulu; V Reddy
Journal:  Acta Paediatr Scand       Date:  1977-09

3.  Leucocyte blood picture in healthy full-term and premature babies during neonatal period.

Authors:  M Xanthou
Journal:  Arch Dis Child       Date:  1970-04       Impact factor: 3.791

4.  Influence of perinatal conditions on C-reactive protein production.

Authors:  N Y Schouten-Van Meeteren; A Rietveld; A J Moolenaar; F Van Bel
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

5.  Can the human neonate mount an endocrine and metabolic response to surgery?

Authors:  K J Anand; M J Brown; R C Causon; N D Christofides; S R Bloom; A Aynsley-Green
Journal:  J Pediatr Surg       Date:  1985-02       Impact factor: 2.545

6.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

Authors:  S Okusawa; J A Gelfand; T Ikejima; R J Connolly; C A Dinarello
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

7.  Plasma interleukin-6 and tumour necrosis factor levels as predictors of disease severity and outcome in necrotizing enterocolitis.

Authors:  J A Morecroft; L Spitz; P A Hamilton; S J Holmes
Journal:  J Pediatr Surg       Date:  1994-06       Impact factor: 2.545

8.  Serum tumour necrosis factor in newborns at risk for infections.

Authors:  E P Girardin; M E Berner; G E Grau; S Suter; G Lacourt; L Paunier
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

9.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Authors:  K J Tracey; S F Lowry; T J Fahey; J D Albert; Y Fong; D Hesse; B Beutler; K R Manogue; S Calvano; H Wei
Journal:  Surg Gynecol Obstet       Date:  1987-05

Review 10.  Immunologic deficiencies in small-for-dates neonates.

Authors:  M Xanthou
Journal:  Acta Paediatr Scand Suppl       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.